The EMILIA trial confirms the survival benefit of T-DM1 in treatment of metastatic breast cancer - http://bit.ly/SuQSCb
1:23 PM - 4 Oct 2012
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.